Ignite Creation Date:
2025-12-24 @ 10:44 PM
Ignite Modification Date:
2026-04-04 @ 7:53 AM
Study NCT ID:
NCT06620835
Status:
RECRUITING
Last Update Posted:
2025-07-29
First Post:
2024-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
Sponsor:
Groupe Francais De Pneumo-Cancerologie
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Optalk GFPC 07-2023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None